In an attempt to isolate novel compounds endowed with muscle- and bone-protective properties, inhibition of the activin receptor 2B (ACVR2B) signaling was shown to enhance muscle mass, increase overall survival in experimental cancer cachexia31,32, and to ameliorate the dystrophic phenotype in mdx mice33. This evidence concerns the gene ACVR2B and cancer.